Provided by Tiger Trade Technology Pte. Ltd.

Adlai Nortye Biopharma Co. Ltd.

15.26
+0.56003.81%
Volume:29.04K
Turnover:442.40K
Market Cap:982.39M
PE:-27.00
High:15.56
Open:14.97
Low:14.70
Close:14.70
52wk High:17.25
52wk Low:0.8786
Shares:64.40M
Float Shares:45.14M
Volume Ratio:0.39
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5649
EPS(LYR):-1.1111
ROE:-20.23%
ROA:-8.70%
PB:4.57
PE(LYR):-13.73

Loading ...

Adlai Nortye Ltd. Sponsored ADR (ANL) Receives a Buy from Cantor Fitzgerald

TIPRANKS
·
Jul 20

Adlai Nortye Doses First US Patient in Weekly Arm of Phase 1 AN9025 Trial

MT Newswires Live
·
Jul 16

Adlai Nortye doses first patient in AN9025 trial

TIPRANKS
·
Jul 16

Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-ras(on) Inhibitor An9025

THOMSON REUTERS
·
Jul 16

Adlai Nortye Director Roger Sawhney Files Initial Beneficial Ownership Statement

Reuters
·
Jul 15

Adlai Nortye Adds MD Anderson’s David Hong, Msk’s Piro Lito to Scientific Advisory Board

Reuters
·
Jul 13

Press Release: Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists

Dow Jones
·
Jul 13

Prince Harry loses privacy case against UK tabloid publisher

CNN Business
·
Jul 07

Analysts Offer Insights on Healthcare Companies: MetaVia (MTVA) and Adlai Nortye Ltd. Sponsored ADR (ANL)

TIPRANKS
·
Jun 09

Adlai Nortye CFO Ye Xiaofeng files initial beneficial ownership statement

Reuters
·
Jun 01

Adlai Nortye files initial beneficial ownership statement for director Alan Ming Lun Tse

Reuters
·
May 29

Adlai Nortye CEO Yang Lu disposes of 10 shares worth $131.8

Reuters
·
May 22

Adlai Nortye files Form 3 for CEO, director Yang Lu as beneficial owner

Reuters
·
May 21

Adlai Nortye President, Head of R&D Archie Tse files initial beneficial ownership statement

Reuters
·
May 20

Adlai Nortye Initiated at Buy by Jones Trading

Dow Jones
·
May 15

Adlai Nortye initiated with a Buy at JonesResearch

TIPRANKS
·
May 15

Analysts Offer Insights on Healthcare Companies: Adlai Nortye Ltd. Sponsored ADR (ANL), Protagonist Therapeutics (PTGX) and Nuvalent (NUVL)

TIPRANKS
·
May 14

Adlai Nortye Ltd : Jonestrading Initiates Coverage With Buy Rating; Price Target $22

THOMSON REUTERS
·
May 14

Legend Biotech Reports First Quarter 2026 Results and Recent Highlights

GlobeNewswire
·
May 12

Adlai Nortye files initial beneficial ownership statement for Kaiyang Tang, Adlai Nortye USA president

Reuters
·
May 08